Arcellx, Inc. DEF 14A: Executive Compensation Details

Ticker: ACLX · Form: DEF 14A · Filed: Apr 17, 2025 · CIK: 1786205

Arcellx, INC. DEF 14A Filing Summary
FieldDetail
CompanyArcellx, INC. (ACLX)
Form TypeDEF 14A
Filed DateApr 17, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: executive-compensation, shareholder-meeting, equity-awards

Related Tickers: ACLX

TL;DR

Arcellx exec comp details out, check equity awards for PEO & others 2022-2024.

AI Summary

Arcellx, Inc. filed its DEF 14A on April 17, 2025, detailing executive compensation and corporate governance for the fiscal year ending December 31, 2024. The filing includes information on equity awards granted to its principal executive officer (PEO) and other employees, with data spanning from 2022 to 2024.

Why It Matters

This filing provides shareholders with crucial information regarding how executive compensation is structured and awarded, impacting company performance and investor confidence.

Risk Assessment

Risk Level: medium — DEF 14A filings are routine but can reveal details about executive compensation and potential shareholder concerns that may influence stock price.

Key Players & Entities

FAQ

What is the primary purpose of this DEF 14A filing?

The primary purpose of this DEF 14A filing is to provide shareholders with information regarding Arcellx, Inc.'s annual meeting of stockholders, including details on executive compensation, director nominations, and corporate governance matters.

What fiscal year does the compensation information primarily cover?

The compensation information primarily covers the fiscal year ending December 31, 2024, with comparative data provided for 2022 and 2023.

What types of equity awards are detailed in the filing?

The filing details various equity awards, including those granted to the Principal Executive Officer (PEO) and Non-PEO Named Executive Officers, covering year-end fair value of outstanding and unvested awards, and changes in fair value.

When was this DEF 14A filing submitted to the SEC?

This DEF 14A filing was submitted to the SEC on April 17, 2025.

What is Arcellx, Inc.'s Standard Industrial Classification (SIC) code?

Arcellx, Inc.'s Standard Industrial Classification (SIC) code is 2836, which corresponds to Biological Products (No Diagnostic Substances).

Filing Details

This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 17, 2025 regarding Arcellx, Inc. (ACLX).

View full filing on EDGAR

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on Read The Filing